W

WuXi XDC Cayman Inc
HKEX:2268

Watchlist Manager
WuXi XDC Cayman Inc
HKEX:2268
Watchlist
Price: 26.7 HKD 6.37% Market Closed
Market Cap: 32B HKD
Have any thoughts about
WuXi XDC Cayman Inc?
Write Note

Operating Margin
WuXi XDC Cayman Inc

22.2%
Current
21%
Average
2.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
22.2%
=
Operating Profit
621.7m
/
Revenue
2.8B

Operating Margin Across Competitors

Country CN
Market Cap 30.6B HKD
Operating Margin
22%
Country US
Market Cap 1.3T USD
Operating Margin
14%
Country US
Market Cap 196.2B USD
Operating Margin
17%
Country US
Market Cap 170.9B USD
Operating Margin
21%
Country KR
Market Cap 67.6T KRW
Operating Margin
31%
Country CH
Market Cap 38.5B CHF
Operating Margin
13%
Country US
Market Cap 38.6B USD
Operating Margin
25%
Country US
Market Cap 36.5B USD
Operating Margin
14%
Country US
Market Cap 26.7B USD
Operating Margin
28%
Country US
Market Cap 23.2B USD
Operating Margin
20%
Country US
Market Cap 23B USD
Operating Margin
29%
No Stocks Found

WuXi XDC Cayman Inc
Glance View

Market Cap
32B HKD
Industry
Life Sciences Tools & Services

WuXi XDC Cayman Inc is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Wuxi, Jiangsu and currently employs 1,113 full-time employees. The company went IPO on 2023-11-17. WuXi XDC Cayman Inc is a holding company primarily engaged in the provision of contract research, development and manufacturing services (CRDMO) for antibody drug conjugates (ADCs) and a wider range of bioconjugate drugs. The firm conducts its businesses through two segments. Research Services on Fee-for-service(FFS) Basis segment providing research services to its customers through FFS contracts. The Research Services on Full-time-equivalent(FTE) Basis segment providing a project team of employees dedicated to the customer's studies for a specific period of time. Based on biopharmaceuticals and small molecule drugs, the Company also provides comprehensive cross-domain services, covering the discovery, process development and good manufacturing practice (GMP) production of bioconjugated drugs, linkers and payloads. The firm conducts its business in domestic and foreign markets.

Intrinsic Value
28.5 HKD
Undervaluation 6%
Intrinsic Value
Price
W

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
22.2%
=
Operating Profit
621.7m
/
Revenue
2.8B
What is the Operating Margin of WuXi XDC Cayman Inc?

Based on WuXi XDC Cayman Inc's most recent financial statements, the company has Operating Margin of 22.2%.